Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 5Phase 1 5Phase NA 1Phase 4 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Vomiting 1Ovarian Neoplasms 1Nausea 1Lung Neoplasms 1Infiltrating Bladder Urothelial Carcinoma 1Fallopian Tube Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brenner Tumor 1

Interventions

Radiosurgery 27Blood Specimen Collection 20Drug Therapy 18Radiotherapy 14Early Intervention, Educational 14Magnetic Resonance Spectroscopy 13Standard of Care 12Pemetrexed 12Carboplatin 12Exercise 11Practice Guidelines as Topic 9X-Rays 8Psychiatric Rehabilitation 8Methods 8Immunotherapy 8Therapeutics 7Surgical Procedures, Operative 7Paclitaxel 7Fluorodeoxyglucose F18 7Surveys and Questionnaires 6Counseling 6Cisplatin 6Biopsy 6Anterior Temporal Lobectomy 6Thoracic Surgery, Video-Assisted 5Liquid Biopsy 5Gemcitabine 5Erlotinib Hydrochloride 5Docetaxel 5Bevacizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Non-Small-Cell Lung × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT02194738 2026-05-29

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡